These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 11693072)

  • 1. [Estimate of the prevalence of hypothyroidism in Castilla y Leon and its trends from 1992 to 2000 based on the use of thyroid hormones].
    Díaz Madero A; López Ferreras A
    Rev Esp Salud Publica; 2001; 75(4):345-52. PubMed ID: 11693072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Estimate of the prevalence of hypothyroidism in Spain based on the use of thyroid hormones (1996-1999)].
    Morant Ginestar C; Criado-Alvarez JJ; García-Pina R; Pérez Garrido B
    Rev Esp Salud Publica; 2001; 75(4):337-44. PubMed ID: 11693071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estimate of hypothyroidism prevalence in Lleida, Spain, based on thyroid hormone prescription].
    Serna Arnáiz MC; Galván Santiago L; Gascó Eguiluz E; Manrique Manrique M; Foix Oña MM; Martín Gracia E
    Rev Esp Salud Publica; 2003; 77(3):405-10. PubMed ID: 12852333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate.
    Treceño C; Martín Arias LH; Sáinz M; Salado I; García Ortega P; Velasco V; Jimeno N; Escudero A; Velasco A; Carvajal A
    Pharmacoepidemiol Drug Saf; 2012 Apr; 21(4):435-41. PubMed ID: 22253017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Incidence of bronchopulmonary carcinoma in Castilla-León in 1997. Multicenter study of the Society of Castilla-León of Respiratory Pathology (SOCALPAR). Study Group for Bronchopulmonary Carcinoma of the SOCALPAR].
    Arch Bronconeumol; 2000 Jun; 36(6):313-8. PubMed ID: 10932340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology of type 1 diabetes in children and adolescents aged less than 15 years in the provinces of Castilla y León].
    Bahíllo Curieses MP; Hermoso López F; García Fernández JA; Ochoa Sangrador C; Rodrigo Palacios J; de la Torre Santos SI; Marugán de Miguelsanz JM; Manzano Recio F; García Velázquez J; Lema Garret TJ;
    An Pediatr (Barc); 2006 Jul; 65(1):15-21. PubMed ID: 16945286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estimation of the prevalence of cerebral palsy in the Autonomous Community of Castilla y León (Spain) using a disabilities register].
    Cancho Candela R; Fernández Alonso JE; Lanza Fernández E; Lozano Domínguez MA; Andrés de Llano JM; Folgado Toranzo I
    An Pediatr (Barc); 2006 Aug; 65(2):97-100. PubMed ID: 16948971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Different methods used to estimate the prevalence of hypothyroidism, Cadiz, Spain].
    Escribano-Serrano J; Paya-Giner C; Méndez Esteban MI; Márquez-Ferrando M; Zarallo-Pérez A; Michán-Doña A
    Rev Esp Salud Publica; 2014 Oct; 88(5):629-38. PubMed ID: 25327271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence of bronchopulmonary cancer in Castilla y Leon and Cantabria in the year 2007. A study by the Castilla y Leon and Cantabria Respiratory Diseases Society (SOCALPAR)].
    Hernández-Hernández JR; Heras-Gómez F; Cordovilla-Pérez MR; Antolín-García T; Bollo De Miguel E;
    Arch Bronconeumol; 2010 Jan; 46(1):7-14. PubMed ID: 19879034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain).
    Moreno-Ramos M; Sánchez-Barba M; Sánchez RG; Mirón-Canelo JA; González-Nuñez V
    Children (Basel); 2021 Dec; 9(1):. PubMed ID: 35053650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Geographic variability in prescribing antibiotics in the pediatric population of Castille and León during 2001-2005].
    Vázquez ME; Pastor E; Bachiller MR; Vázquez MJ; Eiros JM
    Rev Esp Quimioter; 2006 Dec; 19(4):342-8. PubMed ID: 17235403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social and demographic determinants in the prescription of systemic antibiotics.
    Álvarez M; Pastor E; Eiros JM
    Infez Med; 2012 Mar; 20(1):37-48. PubMed ID: 22475659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current status of clinical nutrition at the network of public hospitals from Castilla y León].
    de Luis D; Ballesteros M; Cano I; Fernández M; Izaola O; de la Lama G; López Guzmán A; Maldonado A; Martín MA; Muñoz C; Ruiz E
    Nutr Hosp; 2006; 21(3):357-61. PubMed ID: 16771118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evolution of antipsychotic drug consumption in the autonomous community of Castile and Leon, Spain (1990-2001)].
    García del Pozo J; Isusi Lomas L; Carvajal García-Pando A; Martín Rodríguez I; Sáinz Gil M; García del Pozo V; Velasco Martín A
    Rev Esp Salud Publica; 2003; 77(6):725-33. PubMed ID: 14965064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Paediatric prescribing of anti-asthmatics in primary care in Castilla-León. Geographical variability].
    Casares Alonso I; Cano Garcinuño A; Blanco Quirós A; Pérez García I
    An Pediatr (Barc); 2015 Sep; 83(3):191-200. PubMed ID: 26363566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of antiparkinsonian agents in Castilla-La Mancha. Estimate of prevalence of Parkinson disease].
    Criado-Alvarez JJ; Romo-Barrientos C; Martínez-Hernández J; González-Solana I
    Rev Neurol; 1998 Sep; 27(157):405-8. PubMed ID: 9774809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the diagnostic protocol and age on the prostate cancer incidence rate in Castilla y León according to the national registry 2010.
    Gutiérrez-Pérez MI; González-Sagrado M; Conde-Vicente R; Amón-Sesmero JH
    Actas Urol Esp (Engl Ed); 2021 Jun; 45(5):383-390. PubMed ID: 34088438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actual incidence of prostate cancer in healthcare areas of the autonomous community of Castilla-Leon during 2014. CAPCYL registry data.
    Virseda-Rodríguez AJ; Salvatierra C; García F; Sanz A; Gutiérrez E; Serrano JM; Valverde S; Polo C; Amón-Sesmero JH; Rodríguez V; Cortiñas R; Calleja J; Adriazola M; Gala L; Bermúdez R; Moya I; Szczesniewski RJ; López-Aramburu MA; Gómez-Veiga F
    Actas Urol Esp (Engl Ed); 2018 Nov; 42(9):593-599. PubMed ID: 29292039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of Hypothyroidism in Andalusia, Spain, Determined by Thyroid Hormone Comsumption].
    Escribano-Serrano J; Mancera-Romero J; Santos-Sánchez V; Payá-Giner C; Méndez-Esteban MI; García-Bonilla A; Márquez-Ferrando M; Hormigo-Pozo A; Michán-Doña A
    Rev Esp Salud Publica; 2016 Dec; 90():e1-e12. PubMed ID: 27906155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [M129V PRNP gene polymorphism in Castilla y León shows a similar distribution to other Spanish regions and other European countries].
    Castellanos A; Pérez Prieto M; Castrodeza J; Mirón Canelo JA; González-Sarmiento R
    Med Clin (Barc); 2010 Mar; 134(6):254-6. PubMed ID: 20004419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.